No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs369386019 |
chr12:85674707-85674708 |
Active TSS Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs575902604 |
chr12:85674708-85674709 |
Active TSS Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs145512041 |
chr12:85674745-85674746 |
Active TSS Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs61055357 |
chr12:85674776-85674777 |
Active TSS Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs541153683 |
chr12:85674836-85674837 |
Active TSS Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs559509678 |
chr12:85674837-85674838 |
Active TSS Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs147746524 |
chr12:85674841-85674842 |
Active TSS Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs141010192 |
chr12:85674846-85674847 |
Active TSS Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs138742385 |
chr12:85674860-85674861 |
Active TSS Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs184398335 |
chr12:85674868-85674869 |
Active TSS Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs114662219 |
chr12:85674892-85674893 |
Active TSS Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
12 |
rs543174700 |
chr12:85675086-85675087 |
Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
13 |
rs551098281 |
chr12:85675125-85675126 |
Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
14 |
rs368358947 |
chr12:85675184-85675185 |
Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
15 |
rs114963213 |
chr12:85675226-85675227 |
Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
16 |
rs563551339 |
chr12:85675242-85675243 |
Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
17 |
rs372582944 |
chr12:85675259-85675260 |
Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
18 |
rs188488188 |
chr12:85675269-85675270 |
Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
19 |
rs181293458 |
chr12:85675270-85675271 |
Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
20 |
rs368195661 |
chr12:85675285-85675286 |
Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
21 |
rs530758365 |
chr12:85675291-85675292 |
Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
22 |
rs532547957 |
chr12:85675296-85675297 |
Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
23 |
rs547478116 |
chr12:85675334-85675335 |
Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
24 |
rs566129909 |
chr12:85675374-85675375 |
Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
25 |
rs549151539 |
chr12:85675404-85675405 |
Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
26 |
rs567158949 |
chr12:85675428-85675429 |
Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
27 |
rs536367769 |
chr12:85675445-85675446 |
Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
28 |
rs185067343 |
chr12:85675488-85675489 |
Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
29 |
rs370786073 |
chr12:85675509-85675510 |
Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
30 |
rs534773439 |
chr12:85675565-85675566 |
Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
31 |
rs375058496 |
chr12:85675647-85675648 |
Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
32 |
rs546661945 |
chr12:85675681-85675682 |
Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs191191612 |
chr12:85675691-85675692 |
Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs77383940 |
chr12:85675721-85675722 |
Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs367762736 |
chr12:85675729-85675730 |
Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs180892731 |
chr12:85675731-85675732 |
Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs540978254 |
chr12:85675905-85675906 |
Flanking Active TSS Enhancers Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs552712781 |
chr12:85675932-85675933 |
Flanking Active TSS Enhancers Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs574448360 |
chr12:85675941-85675942 |
Flanking Active TSS Enhancers Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs541540426 |
chr12:85676019-85676020 |
Weak transcription Bivalent Enhancer Enhancers Bivalent/Poised TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs115221316 |
chr12:85676023-85676024 |
Weak transcription Bivalent Enhancer Enhancers Bivalent/Poised TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs144881365 |
chr12:85676056-85676057 |
Weak transcription Bivalent Enhancer Enhancers Bivalent/Poised TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs80043749 |
chr12:85676078-85676079 |
Weak transcription Bivalent Enhancer Enhancers Bivalent/Poised TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs79094146 |
chr12:85676079-85676080 |
Weak transcription Bivalent Enhancer Enhancers Bivalent/Poised TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs557595580 |
chr12:85676149-85676150 |
Weak transcription Bivalent Enhancer Enhancers Bivalent/Poised TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs187200853 |
chr12:85676156-85676157 |
Weak transcription Bivalent Enhancer Enhancers Bivalent/Poised TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs149025659 |
chr12:85676166-85676167 |
Weak transcription Bivalent Enhancer Enhancers Bivalent/Poised TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs532703780 |
chr12:85676198-85676199 |
Weak transcription Bivalent Enhancer Enhancers Bivalent/Poised TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs143086179 |
chr12:85676264-85676265 |
Weak transcription Enhancers Bivalent Enhancer Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs11304530 |
chr12:85676294-85676295 |
Weak transcription Enhancers Bivalent Enhancer Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|